Design has initiated dosing in a Phase 1 clinical trial in healthy volunteers in Australia to evaluate the safety and ...
Initiated Phase 1 Single Ascending Dose Trial of DT-216P2 in Healthy Volunteers; Friedreich Ataxia (FA) Patient Dosing to Begin in mid-2025Dosing ...
Chicago Lane Tech's Daniel Howard is a quick, disruptive three-tech who has six offers including four from Power Four schools. Kansas State is the most recent, offering on Monday, and the Wildcats ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results